Department of Health and Human Services$1.1M obligationsEnds Dec 18, 2021
Federal contract award
HHSN27200004
IGF::OT::IGF 1300017I DUKE UNIVERSITY; VTEU; TASK B1C1; BIOD CAN 8470038; $50,915
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541712 |
| PSC | AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
| Parent award / vehicle | HHSN272201300017I |
| Set-aside | Not reported |
| Pricing type | COST NO FEE |
| Obligations | $1.2M |
| Current contract value | $1.2M |
| Potential contract value / ceiling | $1.2M |
| Start date | Sep 9, 2014 |
| Current end date | Mar 31, 2025 |
| Potential end date | Mar 31, 2025 |
| Latest award activity | Dec 4, 2024 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Dec 4, 2024 | P00011 | $13.2K | A PHASE I, SINGLE DOSE, OPEN-LABEL, PARALLEL GROUP STUDY COMPARING THE PHARMACOKINETICS AND SAFETY OF PA-824 IN SUBJECTS WITH MILD, MODERATE AND SEVERE HEPATIC IMPAIRMENT TO MATCHED, NORMAL, HEALTHY SUBJECTS |
| Nov 20, 2024 | P00010 | $0 | A PHASE I, SINGLE DOSE, OPEN-LABEL, PARALLEL GROUP STUDY COMPARING THE PHARMACOKINETICS AND SAFETY OF PA-824 IN SUBJECTS WITH MILD, MODERATE AND SEVERE HEPATIC IMPAIRMENT TO MATCHED, NORMAL, HEALTHY SUBJECTS |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.